A5046126114- Chronic Myeloid Leukemia Treatments
- Cancer-related molecular mechanisms research
- Cancer Mechanisms and Therapy
- RNA modifications and cancer
- Chronic Lymphocytic Leukemia Research
- Multiple Myeloma Research and Treatments
- RNA Research and Splicing
- Kruppel-like factors research
- Bioactive Compounds and Antitumor Agents
- PI3K/AKT/mTOR signaling in cancer
- Synthesis of Organic Compounds
- Mast cells and histamine
- Acute Lymphoblastic Leukemia research
- Mechanisms of cancer metastasis
- Synthesis of heterocyclic compounds
- Quinazolinone synthesis and applications
- Eosinophilic Disorders and Syndromes
Beijing Institute of Genomics
2024
Chinese Academy of Sciences
2010-2024
University of Chinese Academy of Sciences
2024
Shanghai Center For Bioinformation Technology
2024
Institute of Microbiology
2010-2014
University of Massachusetts Chan Medical School
2008-2010
China Agricultural University
2010
RNA binding protein RBM10 participates in various metabolism, and its decreased expression or loss of function by mutation has been identified many human cancers. However, how dysregulation contributes to cancer pathogenesis remains be determined. Here, we found that was breast tumors, patients with low presented poorer survival rates. depletion cells significantly promotes the cellular proliferation migration. We further demonstrated forms a triple complex YBX1 phosphatase 1B (PPM1B), which...